Preparation and evaluation of posaconazole-loaded enteric microparticles in rats

Min Yang1, Zhonghua Dong1, Yongchun Zhang1

  • 1a School of Pharmaceutical Sciences , Shandong University , Jinan , Shandong , PR China.

Abstract

Insights

Developing enteric microparticles with hypromellose acetate succinate (HPMCAS) via spray drying significantly enhanced the oral bioavailability of posaconazole (POS). Optimizing solvent mixtures was key to achieving desired particle properties and drug release.

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science

Background:

  • Posaconazole (POS) exhibits low oral bioavailability, limiting its therapeutic efficacy.
  • Developing advanced drug delivery systems is crucial for improving POS oral absorption.

Purpose of the Study:

  • To prepare enteric microparticles of posaconazole (POS) using hypromellose acetate succinate (HPMCAS).
  • To enhance the oral bioavailability of POS through optimized microparticle formulation.

Main Methods:

  • POS enteric microparticles were fabricated using HPMCAS via spray drying.
  • Acetone and ethanol solvent mixtures were optimized for microparticle preparation.
  • Multivariate data analysis, including principal component analysis (PCA), was employed to correlate HPMCAS molecular characteristics, particle properties, and drug release kinetics.

Main Results:

  • Optimal spray solvent mixtures were critical for achieving desired POS microparticle properties, including polymer entanglement index, drug surface enrichment, particle size, and drug loading.
  • HPMCAS molecular characteristics influenced the polymer matrix's microscopic connectivity and diffusivity, impacting drug release behavior.
  • The developed microparticles demonstrated enhanced bioavailability of POS.

Conclusions:

  • The selection of appropriate acetone and ethanol solvent mixtures for spray drying is vital for creating entangled polymer structures with specific molecular properties.
  • Fine-tuning particle size and surface drug enrichment resulted in HPMCAS-based enteric microparticles that effectively enhance POS oral bioavailability.